HCM
SNY icon

Hamlin Capital Management’s Sanofi SNY Stock Holding History

Hamlin Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-655,474
Closed -$32.8M – 30
2022
Q2 		$32.8M Sell
655,474
-1,232,830
-65% -$65.4M 1.31% 27
2022
Q1 		$96.9M Buy
1,888,304
+37,622
+2% +$1.94M 3.42% 18
2021
Q4 		$92.7M Buy
1,850,682
+268,535
+17% +$13.3M 3.29% 24
2021
Q3 		$76.3M Buy
1,582,147
+15,909
+1% +$809K 3.04% 24
2021
Q2 		$82.5M Buy
1,566,238
+11,460
+0.7% +$598K 3.25% 22
2021
Q1 		$76.9M Buy
1,554,778
+190,125
+14% +$9.13M 3.15% 21
2020
Q4 		$66.3M Buy
1,364,653
+178,816
+15% +$8.82M 3.06% 23
2020
Q3 		$59.5M Buy
1,185,837
+66,389
+6% +$3.42M 3.15% 24
2020
Q2 		$57.1M Sell
1,119,448
-431,734
-28% -$21M 3.05% 12
2020
Q1 		$67.8M Sell
1,551,182
-210,707
-12% -$10.1M 4.06% 4
2019
Q4 		$88.4M Sell
1,761,889
-14,693
-0.8% -$688K 3.68% 6
2019
Q3 		$82.3M Sell
1,776,582
-108,750
-6% -$4.69M 3.7% 6
2019
Q2 		$81.6M Sell
1,885,332
-2,167
-0.1% -$92.1K 3.5% 9
2019
Q1 		$83.6M Sell
1,887,499
-90,078
-5% -$3.86M 3.72% 9
2018
Q4 		$85.8M Sell
1,977,577
-23,891
-1% -$1.05M 4% 8
2018
Q3 		$89.4M Sell
2,001,468
-65,221
-3% -$2.79M 3.5% 9
2018
Q2 		$82.7M Buy
2,066,689
+295,930
+17% +$11.7M 3.36% 10
2018
Q1 		$71M Buy
1,770,759
+20,930
+1% +$871K 2.74% 19
2017
Q4 		$75.2M Buy
1,749,829
+42,583
+2% +$1.96M 2.89% 18
2017
Q3 		$85M Sell
1,707,246
-17,791
-1% -$861K 3.45% 12
2017
Q2 		$82.6M Sell
1,725,037
-43,486
-2% -$2.08M 3.45% 12
2017
Q1 		$80M Buy
1,768,523
+186,280
+12% +$7.9M 3.38% 12
2016
Q4 		$64M Buy
1,582,243
+14,522
+0.9% +$572K 2.86% 15
2016
Q3 		$59.9M Buy
1,567,721
+212,290
+16% +$8.52M 2.77% 17
2016
Q2 		$56.7M Buy
+1,355,431
New +$55.6M 2.75% 22

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hamlin Capital Management's SNY Position: Q3 2022 in Review

Hamlin Capital Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 655,474 shares — an estimated $32.8M sold.

Hamlin Capital Management first reported a position in SNY in Q2 2016 and held it in 25 quarters. The position peaked at $96.9M in Q1 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Hamlin Capital Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Hamlin Capital Management sold 655,474 Sanofi shares in Q3 2022, an estimated $32.8M.
  • Hamlin Capital Management first reported a position in Sanofi in Q2 2016 and held it in 25 quarters.
  • Hamlin Capital Management's Sanofi position peaked at $96.9M in Q1 2022.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Hamlin Capital Management's 13F filing for Q3 2022, filed 13 Oct 2022.